Antiandrogen withdrawal syndrome with nilutamide

Journal of Urology

Volumn 157, Issue 4, 1997, Pages 1366-

  Gomella, L G ^a   Ismail, M ^a   Nathan, F E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

adenocarcinoma; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN METABOLISM; ANDROGEN WITHDRAWAL SYNDROME; ARTICLE; CASE REPORT; HUMAN; LONG TERM EXPOSURE; MALE; MUTATION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0030966404     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64984-X     Document Type: Article

References (3)

1. Scher H.I. Zhang Z.F. Nanus D. Kelly W.K. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer Urology 47 1996 61
2. Martin W.R. Focus on nilutamide: a non-steroidal antiandrogen for the treatment of advanced prostate cancer Formulary 31 1996 105
3. Herrada J. Dieringer P. Logothetis C.J. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal J. Urol. 155 1996 620